Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

VANI

Vivani Medical Inc

Dec 20 • 04:00PM ET

1.18

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Peers: MDT ABT SYK BSX HOLX ZBH EW ISRG BAX RMD

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.44	Insider Own	49.02%	Shs Outstand	55.27M	Perf Week	-9.92%
Market Cap	69.90M	Forward P/E	-	EPS next Y	-0.44	Insider Trans	15.89%	Shs Float	30.20M	Perf Month	-8.53%
Income	-23.46M	PEG	-	EPS next Q	-0.11	Inst Own	9.69%	Short Float	1.59%	Perf Quarter	-2.48%
Sales	0.00M	P/S	-	EPS this Y	15.33%	Inst Trans	0.64%	Short Ratio	4.31	Perf Half Y	-4.07%
Book/sh	0.33	P/B	3.56	EPS next Y	-4.72%	ROA	-48.77%	Short Interest	0.48M	Perf Year	34.58%
Cash/sh	0.33	P/C	3.56	EPS next 5Y	-	ROE	-105.35%	52W Range	0.84 - 7.80	Perf YTD	15.69%
Dividend Est.	-	P/FCF	-	EPS past 5Y	47.53%	ROI	-64.06%	52W High	-84.87%	Beta	3.23
Dividend TTM	-	Quick Ratio	3.41	Sales past 5Y	-30.20%	Gross Margin	-	52W Low	40.48%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	3.41	EPS Y/Y TTM	16.87%	Oper. Margin	-	RSI (14)	34.43	Volatility	5.48% 4.28%
Employees	44	Debt/Eq	1.09	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	6.00
Option/Short	Yes / Yes	LT Debt/Eq	1.00	EPS Q/Q	17.99%	Payout	-	Rel Volume	2.26	Prev Close	1.18
Sales Surprise	-	EPS Surprise	-4.76%	Sales Q/Q	-	Earnings	Nov 13 BMO	Avg Volume	111.70K	Price	1.18
SMA20	-11.11%	SMA50	-9.02%	SMA200	-18.95%	Trades		Volume	251,926	Change	0.00%

Dec-20-24 05:11AM	Vivani begins exenatide implant trial for obesity in Australia (Medical Device Network)
Dec-19-24 08:30AM	Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia (Business Wire)
08:00AM	EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia (Benzinga)
Dec-04-24 08:30AM	Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast (Business Wire) -5.67%
Nov-13-24 08:35AM	Vivani Medical: Q3 Earnings Snapshot (Associated Press Finance) +11.20%
08:30AM	Loading…
08:30AM	Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-30-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 2 on October 31 Register Now (GlobeNewswire)
Oct-29-24 07:00AM	Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now (GlobeNewswire)
Oct-22-24 08:30AM	Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024 (Business Wire)
Sep-27-24 06:12AM	Vivani Medical obtains Australian approval to begin GLP-1 implant trial (Medical Device Network)
Sep-26-24 12:00PM	Vivani Medical to Test Implant in Obese and Overweight Patients (Exec Edge)
08:30AM	Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia (Business Wire)
08:00AM	EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia (Benzinga)
Sep-25-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 2 on September 26 (GlobeNewswire)
Sep-24-24 07:00AM	Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now (GlobeNewswire)
08:57AM	Loading…
Sep-23-24 08:57AM	Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024 (Business Wire)
Sep-04-24 08:00AM	Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant (Business Wire)
07:33AM	EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity (Benzinga)
Aug-28-24 07:10PM	Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire)
Aug-13-24 04:25PM	Vivani Medical: Q2 Earnings Snapshot (Associated Press Finance) +8.62%
04:05PM	Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-12-24 06:52AM	Vivani to start in-human trial for GLP-1 implant for treating obesity (Medical Device Network)
Jul-11-24 08:00AM	Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115 (Business Wire) +5.60%
07:29AM	EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year (Benzinga)
Jun-13-24 12:58PM	Vivani Medical Receives FDA Clearance for Trial of Type-2 Diabetes Mini-Implant (Exec Edge)
08:25AM	EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED) (Benzinga)
08:00AM	Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant (Business Wire)
May-28-24 09:30AM	EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use (Benzinga)
08:00AM	Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant (Business Wire)
May-13-24 08:52PM	VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024 (InvestorPlace)
04:55PM	Loading…
04:55PM	Vivani Medical: Q1 Earnings Snapshot (Associated Press Finance)
04:45PM	Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results (Business Wire)
May-09-24 08:00AM	Vivani Medical to Present at TIDES Conference 2024 (Business Wire)
Mar-26-24 09:02PM	Vivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial Results (GuruFocus.com)
01:52PM	VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023 (InvestorPlace)
08:38AM	Vivani Medical: Q4 Earnings Snapshot (Associated Press Finance)
08:30AM	Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Mar-06-24 08:00AM	Vivani Medical Appoints Daniel Bradbury to its Board of Directors (Business Wire)
Mar-01-24 07:49AM	Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants (Business Wire) -26.78%
Feb-28-24 01:59PM	Why Is Vivani Medical (VANI) Stock Up 300% Today? (InvestorPlace) +270.30%
08:30AM	Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic/Wegovy and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio (Business Wire)
Nov-14-23 06:10AM	Vivani Medical: Q3 Earnings Snapshot (Associated Press Finance) -6.27%
06:00AM	Vivani Medical Provides Business Update and Reports Third Quarter Financial Results (Business Wire)
Oct-16-23 06:00AM	Vivani Medical to Present at BIO Investor Forum (Business Wire)
Sep-13-23 09:25PM	Director Gregg Williams Acquires 13,997 Shares of Vivani Medical Inc (VANI) (GuruFocus.com)
Sep-07-23 06:00AM	Vivani Medical to Present at the Boulder Peptide Symposium (Business Wire)
Sep-05-23 06:00AM	Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10 (Business Wire)
Aug-14-23 05:56PM	Vivani Medical: Q2 Earnings Snapshot (Associated Press Finance) -10.66%
05:45PM	Vivani Medical Reports Second Quarter Financial Results and Provides Business Update (Business Wire)
Jul-11-23 06:00AM	Vivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis System (Business Wire)
Jun-14-23 06:00AM	Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest (Business Wire)
Jun-13-23 06:05AM	Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth? (Simply Wall St.) +16.30%
May-15-23 06:21AM	Vivani Medical: Q1 Earnings Snapshot (AP Finance) -5.80%
06:15AM	Vivani Medical Reports First Quarter Financial Results and Provides Business Update (Business Wire)
May-03-23 06:57AM	Insiders of Vivani Medical, Inc. (NASDAQ:VANI) received good value on their investment after their US$2.2m purchase jumped US$593k in value (Simply Wall St.) +5.84%
06:26AM	Insider Buying: The Vivani Medical, Inc. (NASDAQ:VANI) Director Just Bought 15% More Shares (Simply Wall St.)
Apr-04-23 06:00AM	Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigents Ongoing Orion Clinical Study (Business Wire)
Mar-31-23 02:50PM	Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Mar-21-23 06:00AM	Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division (Business Wire)
Dec-01-22 09:42AM	We're Hopeful That Vivani Medical (NASDAQ:VANI) Will Use Its Cash Wisely (Simply Wall St.)
Nov-14-22 04:46PM	Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates (Business Wire) -5.33%
Oct-17-22 06:00AM	Vivani Medical to Present at the ThinkEquity Investor Conference (Business Wire)

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Williams Gregg	Director	Nov 08 '24	Buy	1.26	3,968,253	4,999,999	4,695,861	Nov 13 08:46 AM
Dwyer Donald	Chief Business Officer	Oct 01 '24	Buy	1.14	1,000	1,140	48,500	Oct 03 06:10 PM
Dwyer Donald	Chief Business Officer	Oct 02 '24	Buy	1.13	1,000	1,130	49,500	Oct 03 06:10 PM
Dwyer Donald	Chief Business Officer	Oct 03 '24	Buy	1.13	500	565	50,000	Oct 03 06:10 PM
Dwyer Donald	Chief Business Officer	Jul 30 '24	Buy	1.24	5,000	6,200	43,500	Aug 01 08:40 PM
Dwyer Donald	Chief Business Officer	Jul 31 '24	Buy	1.23	4,000	4,920	47,500	Aug 01 08:40 PM
Williams Gregg	Director	Feb 15 '24	Buy	1.01	1,078	1,089	727,608	Feb 20 06:32 PM
Williams Gregg	Director	Feb 08 '24	Buy	1.01	1,119	1,130	725,459	Feb 09 08:02 PM
Williams Gregg	Director	Feb 09 '24	Buy	1.01	1,071	1,082	726,530	Feb 09 08:02 PM
Williams Gregg	Director	Feb 05 '24	Buy	1.01	1,939	1,958	724,284	Feb 06 06:35 PM
Williams Gregg	Director	Feb 06 '24	Buy	1.01	56	57	724,340	Feb 06 06:35 PM
Williams Gregg	Director	Jan 31 '24	Buy	1.01	100	101	722,345	Feb 02 08:04 PM
Williams Gregg	Director	Jan 23 '24	Buy	1.01	834	842	722,245	Jan 25 06:31 PM
Williams Gregg	Director	Jan 22 '24	Buy	1.01	7,620	7,696	721,411	Jan 22 06:54 PM
Williams Gregg	Director	Jan 18 '24	Buy	1.01	999	1,009	713,714	Jan 19 07:27 PM
Williams Gregg	Director	Jan 19 '24	Buy	1.01	77	78	713,791	Jan 19 07:27 PM
Williams Gregg	Director	Jan 16 '24	Buy	1.01	13,067	13,198	712,715	Jan 16 07:24 PM
Williams Gregg	Director	Jan 08 '24	Buy	1.08	6,731	7,269	699,648	Jan 09 08:10 PM
Williams Gregg	Director	Jan 04 '24	Buy	1.07	4,200	4,494	690,917	Jan 05 06:57 PM
Williams Gregg	Director	Jan 05 '24	Buy	1.08	2,000	2,160	692,917	Jan 05 06:57 PM
Williams Gregg	Director	Jan 03 '24	Buy	1.01	3,563	3,599	686,717	Jan 03 08:40 PM
Williams Gregg	Director	Jan 02 '24	Buy	1.01	3,548	3,583	683,154	Jan 03 08:40 PM
Williams Gregg	Director	Dec 22 '23	Buy	1.00	100	100	679,606	Dec 27 06:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VANI

Vivani Medical Inc

Upgrade your FINVIZ experience